Both the lack of significant elevation in serum transaminases due to favipiravir use and the strong relation of AST value with ICU and mortality compared to ALT suggests that the elevation of serum transaminases in COVID-19 may be primarily due to the hyperinflammatory condition and cytopathic effect of the virus. Here, GPT is linked to COVID-19.